A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors
HiFiBiO Therapeutics
HiFiBiO Therapeutics
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Duke University
Duke University